Sven Klussmann
Hoofd Techniek/Wetenschap/O&O bij NOXXON Pharma AG
Actieve functies van Sven Klussmann
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
NOXXON Pharma AG
 NOXXON Pharma AG BiotechnologyHealth Technology NOXXON Pharma AG operates a clinical stage biotechnology company. Its core focus is on cancer treatment. The firm offers effectiveness of cancer treatments including immuno-oncology approaches such as immune checkpoint inhibition and current standards of care such as chemotherapy and radiotherapy. The company was founded in 1997 by Sven Klussmann, Jens-Peter Fürste and Thomas Klein and is headquartered in Berlin, Germany. | Hoofd Techniek/Wetenschap/O&O | 01-01-1997 | - |
| President | 01-01-1997 | 16-11-2009 |
Loopbaan van Sven Klussmann
Eerdere bekende functies van Sven Klussmann
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| TME PHARMA N.V. | Hoofd Techniek/Wetenschap/O&O | 01-01-1997 | - |
| Oprichter | 01-01-1997 | - |
Opleiding van Sven Klussmann
| Freie Universität Berlin | Undergraduate Degree |
Statistieken
Internationaal
| Duitsland | 4 |
Operationeel
| Chief Tech/Sci/R&D Officer | 2 |
| President | 1 |
| Undergraduate Degree | 1 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| TME PHARMA N.V. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
NOXXON Pharma AG
NOXXON Pharma AG BiotechnologyHealth Technology NOXXON Pharma AG operates a clinical stage biotechnology company. Its core focus is on cancer treatment. The firm offers effectiveness of cancer treatments including immuno-oncology approaches such as immune checkpoint inhibition and current standards of care such as chemotherapy and radiotherapy. The company was founded in 1997 by Sven Klussmann, Jens-Peter Fürste and Thomas Klein and is headquartered in Berlin, Germany. | Health Technology |
- Beurs
- Insiders
- Sven Klussmann
- Ervaring
